ono 1078 has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "New drugs and new approaches of the treatment of chronic obstructive pulmonary disease (COPD) are needed." | 2.45 | Targeting leukotrienes for the treatment of COPD? ( Drakatos, P; Karkoulias, K; Lykouras, D; Sampsonas, F; Spiropoulos, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohbayashi, H | 1 |
| Shibata, N | 1 |
| Hirose, T | 1 |
| Adachi, M | 1 |
| Drakatos, P | 1 |
| Lykouras, D | 1 |
| Sampsonas, F | 1 |
| Karkoulias, K | 1 |
| Spiropoulos, K | 1 |
1 review available for ono 1078 and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Targeting leukotrienes for the treatment of COPD?
Topics: 5-Lipoxygenase-Activating Proteins; Acetates; Arachidonate 5-Lipoxygenase; Bronchoconstriction; Capi | 2009 |
1 trial available for ono 1078 and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Additional effects of pranlukast in salmeterol/fluticasone combination therapy for the asthmatic distal airway in a randomized crossover study.
Topics: Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Bronchodilator Age | 2009 |